ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE Drug Patent Profile
✉ Email this page to a colleague
When do Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate patents expire, and when can generic versions of Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate launch?
Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate is a drug marketed by Mikart, Wraser Pharms Llc, Boca Pharma Llc, and West-ward Pharm Corp. and is included in five NDAs.
The generic ingredient in ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
- What are the global sales for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
- What is Average Wholesale Price for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
Summary for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 5 |
DailyMed Link: | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE at DailyMed |